MBP and cancer: Targeted co-delivery of Prodigiosin (PG) and simvastatin (SIM) via a newly synthesized BioMOF coated with the maltose and functionalized with a fusion MBP- D16F7 scFv was introduced to achieve a smart targeting and enhance the synergistic effect of an anti-cancer drug candidate and a cholesterol reducing agent.